BioConnection today announced that they are appointed by Synthon Biopharmaceuticals as development and manufacturing partner for one of their leading antibody projects.
The scope of the project includes the freeze-dry development and the manufacture of a multiple number of clinical scale batches.
"BioConnection gives us access to freeze-dry development services and to their state-of-the-art cGMP manufacturing facilities for parenterals" said Aad van de Leur, Vice President Biopharmaceutical Development at Synthon. "The facilities and network partners of BioConnection enable us to develop our new antibody project from the lab bench to the clinic through only one company. The fact that their manufacturing facilities are within short distance of our main office, is of course very convenient."
"Synthon is one of the best current examples of a successful innovative Dutch pharmaceutical company. It makes us proud and challenges us to have them as one of our customers", said Alexander Willemse, CEO of BioConnection. "When a company like Synthon selects BioConnection it is a proof of the success of our business model, capabilities and facilities."
Synthon, with headquarters in Nijmegen, the Netherlands is an international fast-growing pharmaceutical company and a leader in the field of generic medicines. Synthon has been working in biotechnology since 2007 and is developing rapidly into a specialty pharmaceutical company, focusing on the therapeutic areas of auto-immune disease, multiple sclerosis and oncology. Its products are currently approved by regulatory agencies in over 80 countries worldwide and marketed through strategic partnerships and – in dedicated areas – through direct sales. Synthon employs about 1,400 staff at 11 sites worldwide, and in 2011 it recorded a turnover of EUR 260 million.
BioConnection, based in Oss, is a service provider active in the areas of Product Development and Fill & Finish of biopharmaceutical products. With our best-in-class business partners we are able to provide tailor made solutions to our clients. The cornerstones of our services are the Fill & Finish of sterile liquids (vials, syringes, ampoules and blow-fill-seal) and freeze drying (vials, ampoules). Both are a.o. performed in state-of-the-art cGMP facilities of MSD/Merck&Co in Oss, the Netherlands which are in compliance with the guidelines issued by the US-FDA and EMA.
BioConnection has the means and expertise to assist innovative biotech companies in their endeavours to bring their inventions from the lab bench to the clinic and/ or to the market.